4.6 Article

Epigenetic TET-Catalyzed Oxidative Products of 5-Methylcytosine Impede Z-DNA Formation of CG Decamers

Journal

ACS OMEGA
Volume 5, Issue 14, Pages 8056-8064

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acsomega.0c00120

Keywords

-

Funding

  1. Ratchadaphiseksomphot endowment fund
  2. Chiba Institute of Technology International Academic Fellowship Program for Cooperative Universities

Ask authors/readers for more resources

Methylation of cytosine has been known to play a significant role in epigenetic regulation. 5-Methylcytosine was among the first base modification that was discovered for the capability to facilitate B/Z-DNA transition as observed in CG repeated tracks. A study on gene repression by Z-DNA prone sequence as in ADAM-12 has ignited our research interest for the Z-DNA role in epigenetics. Ten eleven translocation family proteins are responsible to catalyze 5-methylcytosine to produce oxidative products including 5-hydroxymethylcytosine, 5-formylcytosine, and 5-carboxycytosine, which each may have unique function rather than the sole purpose of 5-methylcytosine clearance. Although the Z-DNA-promoting effect of 5-methylcytosine was well established, the effect of its oxidative products on Z-DNA remain unknown. In this study, the Z-DNA-promoting effect of 5-hydroxymethylcytosine, 5-formylcytosine, and 5-carboxycytosine on the CG decamer model were investigated along with known Z-DNA stabilizers, 5-methylcytosine and 8-oxoguanine. Experimental results from circular dichroism (CD) and NMR indicates that all oxidative products of 5-methylcytosine hinder B/Z-DNA transition as high salt concentration suitable to stabilize and convert unmodified CG decamer to Z-DNA conformation is insufficient to facilitate the B/Z-DNA transition of CG decamer containing 5-hydroxymethylcytosine, 5-formylcytosine, or 5-carboxycytosine. Molecular dynamic simulation and free energy calculation by MM-PBSA are in agreement with the experimental finding that 5-hydroxymethylcytosine, 5-formylcytosine, and 5-carboxycytosine destabilize Z-DNA conformation of CG decamer, in contrast to its precursor. Investigation of Z-DNA switch-on/switch-off regulated by 5-methylcytosine and its oxidative products is a further step to elucidate the potential of epigenetic regulated via Z-DNA.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

The conformational effect of para-substituted C8-arylguanine adducts on the B/Z-DNA equilibrium

Vorasit Vongsutilers, Daniel J. Phillips, Brian C. Train, Gregory R. McKelvey, Nissa M. Thomsen, Kevin H. Shaughnessy, James P. Lewis, Peter M. Gannett

BIOPHYSICAL CHEMISTRY (2011)

Article Chemistry, Medicinal

Single C8-Arylguanine Modifications Render Oligonucleotides in the Z-DNA Conformation under Physiological Conditions

Brian C. Train, Suzan A. Bilgesue, Emily C. Despeaux, Vorasit Vongsutilers, Peter M. Gannett

CHEMICAL RESEARCH IN TOXICOLOGY (2014)

Article Biotechnology & Applied Microbiology

The Synthesiis of C8-Aryl Purines, Nucleosides, and Phosphoramidites

Nissa M. Thomsen, Vorasit Vongsutilers, Peter M. Gannett

CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION (2011)

Article Biochemistry & Molecular Biology

A General Synthesis of C8-Arylpurine Phosphoramidites

Vorasit Vongsutilers, Jonathan R. Daft, Kevin H. Shaughnessy, Peter M. Gannett

MOLECULES (2009)

Article Biochemistry & Molecular Biology

5-Methylcytosine containing CG decamer as Z-DNA embedded sequence for a potential Z-DNA binding protein probe

Vorasit Vongsutilers, Kulwadee Sawaspaiboontawee, Bodin Tuesuwan, Yoko Shinohara, Gota Kawai

NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2018)

Article Multidisciplinary Sciences

Pharmaceutical Equivalence of Distributed Generic Antiretroviral (ARV) in Asian Settings: The Cross-Sectional Surveillance Study - PEDA Study

Vorapot Sapsirisavat, Vorasit Vongsutilers, Narukjaporn Thammajaruk, Kanitta Pussadee, Prakit Riyaten, Stephen Kerr, Anchalee Avihingsanon, Praphan Phanuphak, Kiat Ruxrungtham

PLOS ONE (2016)

Review Chemistry, Medicinal

Nitrosamine Contamination in Pharmaceuticals: Threat, Impact, and Control

Bodin Tuesuwan, Vorasit Vongsutilers

Summary: Nitrosamine contamination in medicines has raised safety concerns, leading to stringent guidelines by regulatory authorities. Key to controlling nitrosamine issues is understanding toxicity, potential root causes, risk assessment, and suitable analytical techniques.

JOURNAL OF PHARMACEUTICAL SCIENCES (2021)

Article Chemistry, Medicinal

Basis to Aid Crisis: Favipiravir Oral Solution for Hospital Compounding During COVID-19 Drug Shortage

Bodin Tuesuwan, Wunlapa Mueannoom, Promporn Jamnongtanachot, Ariya Khunvichai, Chiravi Pavitrapok, Kawinthida Wongpakdee, Supasil Sra-ium, Nithi Mahanonda, Vorasit Vongsutilers

Summary: The formulation of favipiravir as a child-friendly dosage form has improved convenience and safety for pediatric patients in Thailand. With the use of pH control and poloxamer as a solubilizing agent, a 200 mg/15 mL oral solution was successfully manufactured and demonstrated stability at 30 degrees C for 30 days and at 5 degrees C for 60 days.

JOURNAL OF PHARMACEUTICAL SCIENCES (2023)

Review Chemistry, Medicinal

Current Threat of Nitrosamines in Pharmaceuticals and Scientific Strategies for Risk Mitigation

Bodin Tuesuwan, Vorasit Vongsutilers

Summary: The current global situation of nitrosamine contamination has expanded to a wide range of medicines due to the possible risk of contamination through various aspects of the drug manufacturing process. Understanding the chemistry, toxicology, and root causes of nitrosamines is crucial for effectively evaluating and mitigating the associated risks. To address the risk of nitrosamine contamination in pharmaceuticals, significant knowledge and resources are required, including reliable laboratory facilities, reference materials, specific instrumentation, data management, and time. Supporting tools such as shared databases, screening models, and in silico models have proven beneficial in managing the risk of nitrosamine contamination.

JOURNAL OF PHARMACEUTICAL SCIENCES (2023)

No Data Available